Where does Bio-Rad Laboratories, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bio-Rad Laboratories, Inc. ranks #767 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bio-Rad Laboratories, Inc. hold?

Bio-Rad Laboratories, Inc. holds 597 US utility patents granted between 2015 and 2025, spanning 82 technology areas.

What is Bio-Rad Laboratories, Inc.'s Innovation Score?

Bio-Rad Laboratories, Inc. has an Innovation Score of 61.6 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bio-Rad Laboratories, Inc. focus on?

Bio-Rad Laboratories, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 313 patents, ranking #34 of 7,863 assignees active in that subclass. Grants appear in 82 CPC subclasses total.

Is Bio-Rad Laboratories, Inc.'s patent grant rate increasing or decreasing?

Bio-Rad Laboratories, Inc.'s recent grant velocity is -8% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bio-Rad Laboratories, Inc.'s patents?

Bio-Rad Laboratories, Inc.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bio-Rad Laboratories, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bio-Rad Laboratories, Inc.

USPTO PatentsView assignee record - 597 granted patents across 82 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bio-rad ranks #767 of 49,997 tracked US assignees by granted-patent volume, with 597 patents across 82 technology areas.

#767
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.6/100): 16.8
avg claims per patent: -8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R767 · US Corporation #767 · 597 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 597 grants
TOP-DECILE #767/49,997
PHOTO-FINISH Donaldson
CPC-WIDE G01N · 82 areas
INNOV-STRONG 61.6/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -8% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Donaldson Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bio-rad’s 61.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.1 pts (36%) Velocity 4.4 pts (7%) Breadth 25.0 pts (41%) Claim depth 10.1 pts (16%)

Qualcomm Incorporated · highest

85
Thyssenkrupp Presta… · near

62
Bio-Rad Laboratories · this assignee

62
Canon Virginia · near

62
Fenwal · near

62
Taiyo Yuden · near

62
3D Lighting… · lowest

7

What this shows Bio-rad's Innovation Score is 61.6/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bio-rad?

Each dot is one of Bio-rad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bio-rad’s own 16.8 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bio-rad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Bio-rad's grant cadence moved

Between 2020–2024, Bio-Rad Laboratories, Inc. received 270 grants versus 293 in 2015–2019 (-8% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 79 grants and bottomed in 2022 at 34. Lead class G01N accounts for 52.4% of the portfolio across 82 subclasses. Volume neighbours: Ethicon Endo-Surgery, Inc. (#763) and Red Hat Israel Ltd. (#771).

Bio-rad's three-year grant acceleration

From 2019–2021 to 2022–2024, Bio-Rad Laboratories, Inc. moved from 194 to 129 grants (0.67x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,267. See the growth leaderboard.

Ethicon Endo-surg…

601
Sunpower

601
Vitesco

601
TDK Taiwan

598
Donaldson

597
Panasonic Liquid…

597
Bio-rad Laborator… ◀

597
Hunter Fan

594
Red Hat Israel

594

What this shows Bio-Rad holds 597 patents at rank #767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bio-Rad

By rank, the assignees closest to #767 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Bio-Rad's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bio-Rad, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Bio-Rad ranks #34 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

Taiyo Yuden Co., Ltd. 62 Fenwal, Inc. 62 Canon Virginia, Inc. 62 Thyssenkrupp Presta Aktiengesellschaft 62

Similar claim depth

Nearest assignees by average claims per patent (16.8 here).

Boston Scientific Scimed, Inc. 16.8 avg Teradata US, Inc. 16.8 avg Faurecia Automotive Seating, LLC 16.8 avg IPG Photonics Corporation 16.8 avg

Bio-rad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bio-Rad Laboratories, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	46	7.7%
2016	55	9.2%
2017	73	12.2%
2018	66	11.1%
2019	53	8.9%
2020	79	13.2%
2021	62	10.4%
2022	34	5.7%
2023	42	7.0%
2024	53	8.9%
2025partial year	34	5.7%

Which technologies does Bio-Rad Laboratories, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 313

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 248

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 174

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 104

C07K - Peptides 76

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 72

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 58

B01D - Separation 53

Y10T - Technical Subjects Covered BY Former US Classification 53

C12Y - Enzymes 38

G02B - Optical Elements, Systems OR Apparatus 29

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 28

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 26

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 21

G06V - Image OR Video Recognition OR Understanding 18

Top 15 of 82 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bio-Rad Laboratories, Inc.'s patent record in context - here's where to go next.

Bio-Rad Laboratories, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 52.4% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #767 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bio-Rad Laboratories, Inc. against Ethicon Endo-Surgery, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.